JBCHEPHARMNSEJB Chemicals & Pharmaceuticals Limited· PharmaceuticalsHighNeutral
Announced Tue, 24 Mar · 19:11 IST

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

Management Changes View source PDF

JBCHEPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹2070.00
prior close
₹2092.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.2-0.3-0.2-0.3-0.2-3.4-5.4-5.7-6.0-3.7-1.0+7.5+7.4
Up moveDown movePending
AI summary

JB Chemicals & Pharmaceuticals announced the results of its postal ballot on five ordinary resolutions, all of which were approved by shareholders with overwhelming majority (over 99% in favor). The key resolution was the appointment of Mr. Aman Mehta (DIN: 08174906) as Managing Director, which received 99.85% support. Additionally, Mr. Aman Mehta was appointed as a Director (99.26%), and three others — Mr. Amal Kelshikar, Mr. Hasmukh Patel, and Mr. Sudhir Menon — were appointed as Non-Executive Non-Independent Directors, each receiving over 99.8% approval. The e-voting was held from February 22 to March 23, 2026, with around 13 crore shares (80.99% of paid-up capital) participating. Promoters voted 100% in favor of all resolutions. The Scrutinizer confirmed the results were fair and transparent.

Likely market impact

Shareholders have given a strong mandate to the new leadership team, especially Mr. Aman Mehta as the new Managing Director, signaling confidence in the company's direction. The near-unanimous approval suggests minimal investor dissent on the board changes.